USE OF CYCLODEXTRINS TO REDUCE ENDOCYTOSIS IN MALIGNANT AND NEURODEGENERATIVE DISORDERS

• 收藏
• 分享

专利权人:

Asdera LLC

发明人:

Knut M. Wittkowski

申请号：

US16086946

公开号：

US20200000840A1

申请日:

2017.03.20

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present disclosure provides certain compositions and methods that may be useful in the treatment and/or prevention of a malignant or neurodegenerative disease or disorder, such as cancer or Alzheimer's disease. Compositions are provided that contain at least one cyclodextrin active agent, such as α-cyclodextrin, or an analogue or derivative thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/